Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
07/27/2000 | CA2356681A1 Metalloproteinase-disintegrin family members: svph dnas and polypeptides |
07/27/2000 | CA2356642A1 Improved phytases |
07/27/2000 | CA2354375A1 Compositions and methods for the diagnosis and treatment of tumor |
07/27/2000 | CA2294572A1 Genetic compositions and methods |
07/26/2000 | EP1022340A1 Stabilisation of compositions comprising non-viral nucleic acid transfer compositions |
07/26/2000 | EP1022339A1 Plasmids, their construction and their use in the manufacture of interleukin-4 and interleukin-4 muteins |
07/26/2000 | EP1022338A2 Viral vaccines |
07/26/2000 | EP1022337A2 Plasmids, their construction and their use in the manufacture of interleukin-4 and interleukin-4 muteins |
07/26/2000 | EP1022336A1 POLYPEPTIDE, cDNA ENCODING THE SAME, AND USE OF THEM |
07/26/2000 | EP1022335A1 High-throughput screening of gene function using libraries for functional genomics applications |
07/26/2000 | EP1022334A2 Novel amylases |
07/26/2000 | EP1022333A1 Human tumor suppressor gene |
07/26/2000 | EP1022332A1 Beta-fructofuranosidase and gene thereof |
07/26/2000 | EP1022331A2 Transdifferentiation of transfected epidermal basal cells into neural progenitor cells, neuronal cells and/or glial cells |
07/26/2000 | EP1022330A2 Transdifferentiation of epidermal basal cells into neural progenitor cells, neuronal cells and/or glial cells |
07/26/2000 | EP1022286A1 POLYPEPTIDE, cDNA ENCODING THE POLYPEPTIDE, AND USE OF THE BOTH |
07/26/2000 | EP1022285A1 Oxidation-resistant ribonuclease inhibitor |
07/26/2000 | EP1021725A1 Early detection of lysosomal storage disorders |
07/26/2000 | EP1021717A1 Method of sorting birds in ovo |
07/26/2000 | EP1021713A2 Broad specificity affinity arrays: a qualitative approach to complex sample discrimination |
07/26/2000 | EP1021562A1 Multiple displacement amplification |
07/26/2000 | EP1021561A1 $g(b)-ADRENERGIC RECEPTOR POLYMORPHISMS |
07/26/2000 | EP1021560A1 Antimicrobial drug screening using a recombinant cell comprising a rna-dependent amidotransferase gene |
07/26/2000 | EP1021559A2 Method and kit for amplification, sequencing and typing of classical hla class i genes |
07/26/2000 | EP1021555A1 STABILIZATION OF $i(HELICOBACTER) UREASE |
07/26/2000 | EP1021554A1 Analyte assay using particulate labels |
07/26/2000 | EP1021553A2 Eukaryotic gene expression cassette and uses thereof |
07/26/2000 | EP1021552A1 Transgenic lemnaceae |
07/26/2000 | EP1021551A1 Plant fatty acid hydroxylase genes |
07/26/2000 | EP1021550A1 Use of beta recombinase in eukaryotic cells, especially for transgenic work |
07/26/2000 | EP1021549A2 SENSE mRNA THERAPY |
07/26/2000 | EP1021548A1 Method for introducing and expressing rna in animal cells |
07/26/2000 | EP1021547A1 Papilloma virus capsomere vaccine formulations and methods of use |
07/26/2000 | EP1021546A1 Neutral sphingomyelinase |
07/26/2000 | EP1021544A2 Chimeric vaccine against tick-borne encephalitis virus |
07/26/2000 | EP1021543A1 Mutants of yeast cdc24p, defective in binding of the g-protein beta subunit |
07/26/2000 | EP1021542A1 Apo-3 ligand |
07/26/2000 | EP1021541A1 Amino-terminally truncated mcp-2 as chemokine antagonists |
07/26/2000 | EP1021540A1 Human progesterone receptor complex p23-like protein |
07/26/2000 | EP1021539A1 A method for selectively controlling membrane protein display and protein secretion in eukaryotic cells |
07/26/2000 | EP1021538A1 Yeast cells expressing modified g proteins and methods of use therefor |
07/26/2000 | EP1021537A1 T cell receptor-associated molecules (trams) and methods of use therefor |
07/26/2000 | EP1021536A2 Mammalian genes involved in viral infection and tumor suppression |
07/26/2000 | EP1021535A2 Human cancer antigen ny eso-1/cag-3 and gene encoding same |
07/26/2000 | EP1021534A1 Hepatitis c receptor protein cd81 |
07/26/2000 | EP1021533A1 Nucleic acids coding for proteins capable of interacting with presenilins |
07/26/2000 | EP1021532A2 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND cDNAs ENCODING THESE PROTEINS |
07/26/2000 | EP1021531A2 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND cDNAs ENCODING THESE PROTEINS |
07/26/2000 | EP1021530A1 PROTEINS ALIKE TO HUMAN COMPLEMENT FACTOR H AND cDNAs ENCODING THESE PROTEINS |
07/26/2000 | EP1021529A2 cDNAs CODING FOR HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS |
07/26/2000 | EP1021528A1 Methods of refolding proteins by use of zwitterionic low molecular weight agents |
07/26/2000 | EP1021527A1 Plant and viral promoters |
07/26/2000 | EP1021526A1 GENE DELETED RECOMBINANT FeLV PROVIRAL DNA FOR PRODUCTION OF VACCINES AGAINST FeLV |
07/26/2000 | EP1021465A2 Gfp-annexin fusion proteins |
07/26/2000 | EP1021464A1 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle |
07/26/2000 | EP1021460A1 Laminins and uses thereof |
07/26/2000 | EP1021202A1 Immunogenic peptides from the hpv e7 protein |
07/26/2000 | EP1021201A1 Use of growth differenciation factor-9 (gdf-9) as a contraceptive |
07/26/2000 | EP1021092A4 Food products containing structured triglycerides |
07/26/2000 | EP1021092A1 Food products containing structured triglycerides |
07/26/2000 | EP1021080A1 Coat protein mediated resistance in plants |
07/26/2000 | EP1007964A4 FORMATION AND USE OF PRION PROTEIN (PrP) COMPLEXES |
07/26/2000 | EP0992577B1 Process for microinjection and nanopipette for introducing an injection product, particularly foreign genetic material in procaryotic or eucaryotic cells or cellcomparments thereof (plastides, cell nucleus) |
07/26/2000 | EP0904541A4 PURIFICATION OF TISSUE PLASMINOGEN ACTIVATOR (tPA) |
07/26/2000 | EP0870063B1 Fluorescence detection assay for homogeneous pcr hybridization systems |
07/26/2000 | EP0832134B1 Anti-allergy bispecific molecules |
07/26/2000 | EP0828752A4 Chitotriosidase |
07/26/2000 | EP0786084A4 Method for screening compositions |
07/26/2000 | EP0769054B1 Immunomodulators |
07/26/2000 | EP0755458A4 Electrogenerated chemiluminescence labels for analysis and/or referencing |
07/26/2000 | EP0629293B1 Assay for adrenal autoantibodies |
07/26/2000 | CN1261407A Method based on use of bacteriophages for detection hiological molecules in biological samples |
07/26/2000 | CN1261406A Reverse transcription method |
07/26/2000 | CN1261404A Lentivirus-Based gene transfer vectors. |
07/26/2000 | CN1261403A Surface exposed proteins from chlamydia pneumoniae |
07/26/2000 | CN1261402A Plant and viral promotors |
07/26/2000 | CN1261400A Laundry and cleaning compositions containing xyloglucanase enzymes |
07/26/2000 | CN1261373A Compositions and methods for activating genes of interest |
07/26/2000 | CN1261281A Peptide parathyroid hormone analogs |
07/26/2000 | CN1261105A Human gene pRb-BP125 reacting on anticancer gene coding resultant pRB |
07/26/2000 | CN1261104A Human oxido-reductase subunit and its coding sequence, preparing process and application |
07/26/2000 | CN1261103A Human targeting glycogen protein,and its coding sequence, preparing process and application |
07/26/2000 | CN1261102A Human spindle protein and its coding sequence, preparing process and application |
07/26/2000 | CN1261101A Method for dwarfing plants |
07/26/2000 | CN1261075A Recombination virus able to specifically kill tumor cells associated with EB virus and building process |
07/26/2000 | CN1260998A Recombination adenovirus and its application in tumor treatment |
07/26/2000 | CN1054881C New type recombinant DNA containing luciferase gene and production method of luciferase |
07/25/2000 | US6093874 Methods for improving seeds |
07/25/2000 | US6093873 Genetically engineered mice containing alterations in the gene encoding RXR |
07/25/2000 | US6093872 Human fetal liver tissue and human fetal thymus is introduced into a vascularized site of an immunocompromised mouse at a site supplied with a vascular system; the fetal tissue results in formation of functional human bone marrow tissue |
07/25/2000 | US6093811 Oligonucleotide modulation of cell adhesion |
07/25/2000 | US6093810 Nematode-induced genes in tomato |
07/25/2000 | US6093809 Nucleotide sequence; anticarcinogenic and antiaging agents; diagnostic applications; evolutionary (e.g., phylogenetic) investigations |
07/25/2000 | US6093808 IκBEGFP constructs, cell lines and methods of use |
07/25/2000 | US6093802 Culturing cells transformed to express a nerve growth factor of specific amino acid sequence, activity, or weight and isolating protein; for treatment of alzheimer's/parkinson's diseases, amyotrophic lateral sclerosis, and nerve damage |
07/25/2000 | US6093800 Amino acid sequence of cell surface protein; diagnostic markers of cancer, including hormone refractory prostate cancer; anticarcinogenic agents |
07/25/2000 | US6093796 Recombinant hK2 polypeptide |
07/25/2000 | US6093794 Amino acid sequence of a 16 to 39 amino acids with modified n-and c-terminals; with viricidal and antifusogenic activity against retroviruses; prevention of human immunodeficiency virus transmission to uninfected cd4+ cells |
07/25/2000 | US6093700 Method of inducing an immune response using vaccinia virus recombinants encoding GM-CSF |
07/25/2000 | US6093695 Bacillus thuringiensis CryET29 compositions toxic to coleopteran insects and ctenocephalides SPP |